Tau endo-lysosomal processing in human iPSC-derived microglia is impacted by tau aggregation state, but not by microglial activation status
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Microglia are the tissue resident macrophages of the brain and their contribution to tau pathology progression remains to be fully understood. In this study, we developed a quantitative platform to elucidate the endo- lysosomal regulation of tau within human induced pluripotent stem cell (iPSC)-derived microglia. We show that iPSC-derived microglia internalize monomeric and fibrillar tau through different cellular mechanisms and with different degradation kinetics. Acute inflammatory activation of microglia alters tau endocytosis, but surprisingly does not impact lysosomal clearance. These results highlight the importance of the microglial endo-lysosome system as a regulator of tau pathology that is decoupled from acute microglial activation.
Highlights
-
Human iPSC-derived microglia endocytose tau using different cellular mechanisms
-
NanoBiT system can measure tau endocytosis/degradation in iPSC-derived microglia
-
Aggregation of tau impacts the rate of lysosomal degradation after endocytosis
-
Acute inflammation affects total endocytosed tau, but not degradation in microglia
